Articles tagged with Peptides
A collaboration between University of Toronto and National Jewish Health has yielded a new drug discovery that could combat inflammation and acute respiratory illnesses like COVID-19. The 'drug' is a combination of two naturally occurring peptides, TAT CARMIL1, which reduces collagen degradation by up to 43%.
Researchers at Rensselaer Polytechnic Institute have engineered peptides that bind selectively to polysialic acid on cells, potentially providing a barrier against viruses. The findings suggest these peptides could be used to treat diseases such as Alzheimer's, Parkinson's, and cancer.
Researchers developed a new calcium indicator that accumulates only in neuron bodies, reducing crosstalk and improving signal accuracy. This breakthrough allows for more precise monitoring of individual neurons and their roles in brain functions.
Researchers created transgenic rice with anti-hypertensive peptides that lowered blood pressure in hypertensive rats. The effect remained after a 5-week treatment period without obvious side effects. If effective in humans, it could lead to a daily intake of only half a tablespoon of special rice.
Scientists at the University of Würzburg have identified thousands of cryptic HLA peptides in tumor immunopeptidomes using a novel bioinformatics method. These peptides may serve as effective targets for cancer immunotherapies and vaccines against virus-infected cells.
Researchers at Northwestern University have developed a family of soft materials that imitates living creatures, bending, rotating and even crawling on surfaces when hit with light. The materials move without complex hardware or electricity, and have potential applications in energy, environmental remediation and advanced medicine.
A protein fragment derived from soybeans has been shown to improve working and long-term memory in mice with simulated Alzheimer's disease. The dipeptide, named Tyr-Pro, is the first known molecule to enter the brain intact after ingestion.
A method for self-assembling nanostructures with gamma-modified peptide nucleic acid (γPNA) has been developed by Carnegie Mellon University researchers. The process enables the formation of complex, all-PNA nanostructures in organic solvent solutions, holding promise for nanofabrication and nanosensing.
Researchers analyzed the genetic variability of immunity in response to COVID-19, identifying key HLA molecules that contribute to individual susceptibility. The study found significant differences in HLA variant frequencies across populations, suggesting past adaptations to different pathogenic pressures.
Researchers at MIT develop an automated tabletop machine that can synthesize hundreds of amino acids within hours, reducing the time required to generate synthetic proteins. This technology could speed up the manufacturing of on-demand therapies and enable scientists to design artificial proteins with superior biological function.
The study reveals that imidazole catalyzes the formation of prebiotic peptides, shifting the activation site from N-terminus to O-terminus. This finding sheds light on the origin of life and proposes a new hypothesis for its emergence.
Researchers at the University of Ottawa have discovered a new sex hormone in zebrafish that regulates sexual behavior and reproduction. The hormone, secretoneurin peptide, was found to restore sexual function in genetically modified fish by increasing hormone release and enhancing ovulation.
Researchers have successfully developed a method to create proteolytically resistant therapeutic peptides that can survive the gastrointestinal tract. This breakthrough enables the development of oral peptide drugs targeting gastrointestinal targets, such as Crohn's disease and ulcerative colitis.
Scientists have developed nanodevices that capture and trap beta-amyloid peptides, a key component of Alzheimer's plaques. The devices show promise in preventing plaque formation and reducing cell death, with over 90% efficiency compared to control particles.
UMass Amherst scientists used computational techniques to study amyloid fibril growth and brain pathology, revealing that earlier forms of the protein are toxic. The research provides a comprehensive understanding of the process, highlighting the importance of energy landscapes in disease progression.
Researchers at the University of Utah and Texas Advanced Computing Center used powerful supercomputers to rapidly generate molecular models of compounds relevant for COVID-19. They applied their approach, developed previously for Ebola virus research, to identify promising peptides that can disrupt the coronavirus.
A Japanese research team has developed a cyclic peptide that enhances blood-brain barrier penetration, allowing for the delivery of macromolecular drugs to the brain. The technology, which uses nanoparticles and liposomes, shows promise in treating central nervous system diseases such as Alzheimer's.
Researchers have identified specific Bifidobacteria strains that can break down gluten proteins into smaller fragments, reducing immune response damage. These findings pave the way for new treatments and improved patient outcomes for celiac disease patients.
Researchers at Nagoya University have discovered a hormone produced in nitrogen-starved leaves that regulates the demand and supply of nitrogen between plant shoots and roots. The hormone, CEPDL2, enhances nitrate uptake efficiency, potentially minimizing fertilizer use.
A team of scientists used machine learning to speed up the process of identifying optimal self-assembling peptides for biocompatible electronic devices. By screening 8,000 candidates, they were able to rank each design and pave the way for experimentalists to test the most promising ones.
Researchers have identified a promising first step in antiviral treatment for COVID-19, focusing on the spike protein's fusion peptide. By understanding how this peptide interacts with host cells, scientists hope to develop an antibody that can block viral entry and replication.
A new study found that a novel peptide antagonist given in combination with a PD-1 inhibitor is safe and well-tolerated in patients with advanced, refractory pancreatic and rectal cancer. The highest dose tested resulted in no adverse events leading to the recommendation for use in future trials.
Researchers at Texas A&M University have successfully harnessed bacteria's ability to create peptides with noncanonical amino acids, enabling the expansion of phage display libraries. This new method paves the way for new peptide-based therapeutics in cancer and other human diseases.
Researchers identified peptides that trigger immune responses in multiple plant species, including citrus, potentially preventing or reducing yield loss from citrus greening. This discovery offers a new hope for the devastated citrus industry, where no resistant varieties are available and limited disease control measures exist.
Researchers developed a new technique called zombie scanning to study peptide-receptor interactions on the cell surface. This method hijacks cell machinery to simplify the creation of peptides, allowing for rapid studies and lower production costs.
Scientists have created two-layered nanofibers consisting of an ordered row of alternating peptides and determined what drives their self-assembly. The discovery has potential biomedical applications due to the ability to tailor peptide structures.
Weizmann Institute researchers found that overexpression of specific immunoproteasome subunits in melanoma is tied to anti-cancer immune activity. The study's findings suggest that these biomarkers may improve patient matching to current immunotherapy treatments, leading to better outcomes.
Researchers at NYU Abu Dhabi have designed proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of amyloid-β protein associated with Alzheimer's disease. The CPPs stabilize Aβ in a non-aggregated state, inhibiting neurotoxicity and protecting neurons from damage.
Researchers at the Technical University of Berlin introduce a new method to synthesize α-amanitin, a highly selective inhibitor of RNA polymerase II. This synthetic route allows for large-scale production and could lead to cancer treatment advancements.
Researchers at Washington State University and UMass Amherst will explore the role of bacterial fragments in regulating sleep and circadian rhythms. They aim to determine how these fragments affect brain functions, including sleep, cognition, mood, and appetite.
Researchers at the Centre for Addiction and Mental Health have identified a protein complex elevated in PTSD patients, which could serve as a blood-based biomarker for diagnosis and treatment. A developed peptide has been shown to prevent recall or encoding of fear memories, suggesting potential for symptom prevention or treatment.
A team of scientists from Tokyo Metropolitan University discovered that a specific insulin-like peptide called ILP2 regulates the size of mandibles in broad-horned flour beetles. The study found that larvae fed sufficiently, showed elevated expression of ILP2, leading to larger mandibles.
Researchers from the University of Freiburg and US universities have developed a method to differentiate between individual amino acids in short peptides. They used an aerolysin nanopore to measure the ion current through the pore, enabling the sensitive measurement of peptide size and structure.
IBP-CP24, a newly engineered peptide, exhibits prolonged half-life and potent anti-HIV activity, including effectiveness against drug-resistant strains. Its combination with broad neutralizing antibodies may reduce treatment costs.
Researchers discovered a new mechanism for detecting foreign material during early immune responses, which could help detect elusive cancers. ERAP1 protein can break down peptides bound to MHC I, allowing immune cells to recognize and destroy infected cells.
Researchers at the University of Illinois Chicago found a peptide called PACAP links migraine pain and opioid-induced pain, offering potential new treatments for episodic migraines. The study's findings support the development of therapies targeting PACAP and its receptor.
AFAR presents its Scientific Awards of Distinction to Pinchas Cohen, M.D., and Nathan LeBrasseur, Ph.D., recognizing their pioneering work in understanding cellular senescence and the discovery of novel peptides. The awards honor exceptional contributions to aging research and come with a cash prize and framed citations.
Researchers from the University of Copenhagen have identified five new GPCRs activated by 17 peptide ligands, expanding the known peptide-GPCR network. This discovery has high translational potential as therapeutic targets for various diseases, including genetic, nervous system, and neoplastic disorders.
Researchers at the University of Iowa have made significant breakthroughs in delivering gene-editing proteins to airway cells without causing harm. The new peptide-based platform shows promise in treating diseases like cystic fibrosis, COPD, and asthma by repairing or modifying disease-causing mutations.
Scientists have developed a simple way to transport medication into the brain, bypassing the blood-brain barrier. The new technique uses engineered particles that can be packed with drugs and delivered through an intravenous injection, offering a minimally invasive solution for treating neurological disorders.
Researchers found that deliquescent minerals can assist the construction of proteins from simpler building blocks during cycles timed to mimic day and night on early Earth. This process, which avoids unpredictable storms, may have played a key role in the origins of life.
Researchers at Lehigh University have created a new biofabrication method that allows for the regeneration of multiple tissues, such as cartilage and bone, within a single scaffold. This breakthrough could potentially treat debilitating conditions like osteoarthritis, which affects approximately 27 million Americans.
A team of UC Davis researchers led by Vladimir Yarov-Yarovoy is developing a new class of peptides to treat chronic pain with minimal side effects. The goal is to identify the most effective peptide design that can selectively block pain-associated sodium channels without affecting other channels.
Researchers have developed a way to track the formation of soluble amyloid beta peptide aggregates implicated in the onset of Alzheimer's disease. The ruthenium-based fluorescent complexes bind to these aggregates, allowing researchers to monitor their progress and movements over time.
A team of MIT researchers developed an AI-guided robotic platform to streamline the synthesis of small molecule organic compounds. The platform uses artificial intelligence-driven synthesis planning, flow chemistry, and a robotically controlled experimental platform to minimize human intervention.
Scientists at Boyce Thompson Institute have identified two plant genes, CLE53 and CLE33, which help control fungal colonization levels in plant roots. These genes can potentially be used to enhance crop phosphate capture, reducing environmental harm from fertilization.
Researchers have developed a self-assembling peptide hydrogel that increases blood vessel regrowth and neuronal survival in rats with traumatic brain injuries. The treatment also improves the survival of brain cells and shows signs of new blood vessel formation.
Researchers developed molecules that can change unhealthful gut microbiomes into more healthful ones in mice, reducing cholesterol levels and inflammation. The study could lead to new treatments for chronic diseases related to diet.
University of Minnesota researchers have discovered a novel cellular process called 'bystander uptake' that allows cells to engulf nano-sized materials without direct peptide functionalization. The study found that cysteine surrounding the cells stimulates this activity.
Researchers used a far-infrared free-electron laser to break down amyloid fibril aggregates, disrupting their rigid sheet-like structure and causing free peptides to form. This technique has potential applications in medicine, biomaterial engineering, and regenerative medicine.
Researchers at Scripps Research Institute find that proteinaceous amino acids react more efficiently, leading to the formation of complex life forms. The study suggests a possible explanation for the selection of positively charged amino acids in proteins.
Researchers at UMass Amherst have expanded the functions of conducting microbial nanowires, developing them into sustainable chemical and biological sensors. The new nanowires can be modified with peptides to specifically bind chemicals or biologics, offering promising possibilities for biomedical and environmental applications.
Researchers at the University of Illinois have discovered a novel biosynthetic pathway in bacteria that can produce therapeutic compounds. The pathway, found in Pseudomonas syringae, combines elements of both ribosome-based and enzyme-mediated synthesis, allowing for efficient production of natural products.
Researchers have identified a new mechanism for how plants perceive RALF23 peptides, a key player in regulating important plant processes. The discovery sheds light on how plants respond to internal and external cues, with potential implications for understanding immune defense and development.
A UCL study reveals that aminonitriles, the precursors to amino acids, can be easily turned into peptides in water, bypassing traditional formation methods. This discovery sheds light on how life first formed and has implications for synthetic chemistry.
Scorpion venom contains compounds that bind to K+ channels, inhibiting their function. High-speed atomic force microscopy revealed the association and dissociation dynamics of a peptide, AgTx2, with the K+ channel KcsA. The study found that AgTx2 binding is facilitated by an induced-fit mechanism, accelerating binding by 400-fold.
Researchers from the University of Córdoba have analyzed the peptide content of goat milk kefir and discovered 11 beneficial compounds. These findings suggest that fermented kefir may have positive effects on cardiovascular health, immune function, and more.
Researchers at MIT used NMR spectroscopy to determine the structure of glucagon fibrils, finding a novel antiparallel beta sheet conformation and steric zippers that make the protein stable. This discovery may lead to shelf-stable versions of the hormone, which is used to control diabetes.
A recent study found that over half of relapsed multiple myeloma patients treated with carfilzomib experienced cardiac issues during treatment. The study recommends routine monitoring with natriuretic peptide testing to mitigate this risk.
Researchers at Goethe University have developed a novel method for producing new peptide drugs, using fragments of natural NRPS systems as building blocks. The approach enables the easy production of peptides in excellent yield, with applications for modifying clinically relevant drugs and producing peptide libraries.